BICLUSTER_ID : UPREG-42
PATHOGENS /2/ : pseudomonas aeruginosa,yersinia enterocolitica
TARGETS /24/ : CKB, CCL20, UAP1, CCL2, LPL, SERPINB2, CYP1B1, GCH1, TXNRD1, BRAF, FGF2, NFKB1, SLC12A7, XDH, JAK2, NP, PPARG, HS3ST3A1, IL6, SERPINE1, PTGS2, F3, IL1R1, PLAUR
Gene SetLeading Edge Genes
NETPATH TGFBETA RECEPTOR PATHWAY UPDDX21, MAP3K8, ETS1, CLCF1, IFI35, CYP1B1, FURIN, EIF2C2, ETV6, BHLHB2, EGR2, JAK2, JUNB, EDN1, MAPK6, TNFRSF12A, SPON2, TOPORS, PFKP, SERPINB9, IFRD1, F3, JAG1, CKB, CCRN4L, GADD45B, UAP1, CDKN1A, ELA3A, ARID5A, IER3, FGF2, SLC12A7, DSCR1, NP, PTPRC, IVL, DDIT4, ETS2, IL6, HS3ST3A1, ATF3, PTGS2, DAXX, PLAUR
NETPATH IL 1 PATHWAY UPNFKB1, CCL20, LIF, CXCL1, NP, SERPINB2, IL1A, CXCL5, IL6, PTGS2, CXCL2, TXNRD1, PTX3
GERY CEBP TARGETSGADD45B, LPL, SERPINB2, RGS16, GCH1, MAFK, PTX3, XDH, CXCL1, JUNB, KLF4, PPARG, CXCL5, ATF3, IFRD1, PLAUR, DUSP1
NETPATH IL 4 PATHWAY DOWNCCL20, GADD45B, CDKN1A, CCL2, LPL, IL6, PTGS2, IRF1, CXCL2
NETPATH IL 2 PATHWAY UPDDX21, FRMD4B, ETS1, RGS16, TRAFD1, PMAIP1, TXNRD1, BHLHB2, CFLAR, IER3, IFIT1, NFKB1, B4GALT5, KLF6, LIF, CSF1, PTPRC, TRIM21, ETS2, IL6, SERPINE1, DAXX, IRF1, PLAUR
NCI IL23PATHWAYNFKB1, IL6, CXCL1, JAK2, CCL2
NETPATH EGFR1 PATHWAY UPLIF, PHLDA1, CDKN1A, EREG, PLK2, NP, SERPINB2, EHD1, CXCL5, PTGS2, TNFAIP3, SDC4, DUSP1, PLAUR, IER3
NCI IL12 2PATHWAYNFKB1, GADD45B, JAK2, IL1R1
NETPATH TNF ALPHA PATHWAY DOWNCCL20, ITGB4BP, CXCL1, JUNB, MAFF, DUSP2, IL6, PTGS2, TNFAIP3, SDC4, CXCL2, IRF1, BHLHB2, IER3
NCI REG GR PATHWAYNFKB1, IL6, CDK5R1, CDKN1A, IRF1, NR1I3
NETPATH IL 5 PATHWAY UPNFKB1, NFKBIB, PLSCR1, REL, CCL2, IL1A, IER3, EGR2
ST P38 MAPK PATHWAYNFKB1, DUSP10, IL1R1, DUSP1
NCI IL1PATHWAYNFKB1, SQSTM1, IL1RN, IL1R1, IL1A, UBE2N, TOLLIP
NETPATH IL 9 PATHWAY UPCCL2, JUNB
NETPATH IL 7 PATHWAY UPCXCL5, CXCL1, CXCL2, BRAF
NETPATH IL 6 PATHWAY UPMAFF, GADD45B, CXCL1, JUNB, IRF1, MAP3K8, PPARG, BHLHB2
BIOCARTA IL10 PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
BIOCARTA STEM PATHWAY
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
WEINMANN ADAPTATION TO HYPOXIA DN
VARELA ZMPSTE24 TARGETS UP
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
LINDSTEDT DENDRITIC CELL MATURATION B
BIOCARTA IL1R PATHWAY
KRASNOSELSKAYA ILF3 TARGETS UP
RASHI RESPONSE TO IONIZING RADIATION 2
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
KIM WT1 TARGETS 12HR DN
AMIT EGF RESPONSE 480 HELA
JEON SMAD6 TARGETS UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
BOYAULT LIVER CANCER SUBCLASS G56 DN
HINATA NFKB TARGETS KERATINOCYTE UP
DORN ADENOVIRUS INFECTION 48HR DN
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
MARKEY RB1 ACUTE LOF UP
AMIT SERUM RESPONSE 60 MCF10A
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
HAN SATB1 TARGETS DN
SABATES COLORECTAL ADENOMA UP
REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY
MCBRYAN PUBERTAL BREAST 3 4WK UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
WOTTON RUNX TARGETS UP
LIU VAV3 PROSTATE CARCINOGENESIS UP
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
AMIT EGF RESPONSE 120 HELA
NCI CHEMOKINE RECEPTORS BIND CHEMOKINES
BIOCARTA RANKL PATHWAY
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
MCLACHLAN DENTAL CARIES UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
PODAR RESPONSE TO ADAPHOSTIN UP
LEE LIVER CANCER E2F1 UP
HELLER SILENCED BY METHYLATION UP
KERLEY RESPONSE TO CISPLATIN UP
BOWIE RESPONSE TO TAMOXIFEN
SMID BREAST CANCER LUMINAL B DN
ZHOU INFLAMMATORY RESPONSE LPS UP
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
VANTVEER BREAST CANCER ESR1 DN
DORN ADENOVIRUS INFECTION 24HR DN
FALVELLA SMOKERS WITH LUNG CANCER
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
NCI P53DOWNSTREAMPATHWAY
CORUM IKBEPSILON-RELA-CREL COMPLEX
TIAN TNF SIGNALING VIA NFKB
ST STAT3 PATHWAY
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
HOFMANN MYELODYSPLASTIC SYNDROM LOW RISK DN
HUANG DASATINIB RESISTANCE UP
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
HINATA NFKB TARGETS FIBROBLAST UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
ZHANG INTERFERON RESPONSE
KEGG ASTHMA
SESTO RESPONSE TO UV C1
CROONQUIST STROMAL STIMULATION UP
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
SIMBULAN UV RESPONSE NORMAL UP
KIM LRRC3B TARGETS
HORIUCHI WTAP TARGETS UP
WOO LIVER CANCER RECURRENCE UP
DORN ADENOVIRUS INFECTION 12HR UP
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP
KEGG JAK STAT SIGNALING PATHWAY
FUNG IL2 SIGNALING 2
TURASHVILI BREAST DUCTAL CARCINOMA VS DUCTAL NORMAL DN
DER IFN BETA RESPONSE UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
DIRMEIER LMP1 RESPONSE LATE UP
SEIKE LUNG CANCER POOR SURVIVAL
BIOCARTA CYTOKINE PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
MUELLER METHYLATED IN GLIOBLASTOMA
BASSO CD40 SIGNALING UP
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
ENK UV RESPONSE EPIDERMIS DN
ZERBINI RESPONSE TO SULINDAC UP
WANG ESOPHAGUS CANCER VS NORMAL UP
CROMER TUMORIGENESIS UP
FRIDMAN SENESCENCE UP
WU HBX TARGETS 2 DN
MAHADEVAN RESPONSE TO MP470 UP
CORRE MULTIPLE MYELOMA UP
FERRARI RESPONSE TO FENRETINIDE UP
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
NCI SYNDECAN PATHWAY
SANA RESPONSE TO IFNG UP
SIG CD40PATHWAYMAP
KEGG LEISHMANIA INFECTION
WU HBX TARGETS 1 UP
CHEN HOXA5 TARGETS 9HR UP
WANG RECURRENT LIVER CANCER DN
SEKI INFLAMMATORY RESPONSE LPS UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
MURAKAMI UV RESPONSE 6HR UP
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
MOSERLE IFNA RESPONSE
FOSTER INFLAMMATORY RESPONSE LPS UP
WANG METHYLATED IN BREAST CANCER
BIOCARTA ASBCELL PATHWAY
SENESE HDAC1 TARGETS UP
LIU TARGETS OF VMYB VS CMYB DN
KIM WT1 TARGETS UP
ONDER CDH1 TARGETS 1 DN
KEGG CYTOSOLIC DNA SENSING PATHWAY
BIOCARTA GRANULOCYTES PATHWAY
LINDSTEDT DENDRITIC CELL MATURATION C
DORSAM HOXA9 TARGETS DN
ELVIDGE HYPOXIA BY DMOG UP
AMIT EGF RESPONSE 120 MCF10A
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
SMID BREAST CANCER RELAPSE IN BONE DN
PRAMOONJAGO SOX4 TARGETS UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
BIOCARTA PML PATHWAY
REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
TENEDINI MEGAKARYOCYTE MARKERS
MCBRYAN PUBERTAL BREAST 4 5WK UP
NETPATH IL 1 PATHWAYNFKBIB, IL1RN, PELI1, IL1A
LINDSTEDT DENDRITIC CELL MATURATION A
XU RESPONSE TO TRETINOIN UP
HOFMANN CELL LYMPHOMA DN
ELVIDGE HYPOXIA UP
CORUM IKBBETA-RELA-CREL COMPLEX
NCI SYNDECAN 1 PATHWAY
BIOCARTA NKT PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
ROETH TERT TARGETS UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
BIOCARTA LAIR PATHWAY
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 UP
VART KSHV INFECTION ANGIOGENIC MARKERS UP
OSADA ASCL1 TARGETS DN
BIOCARTA LYM PATHWAY
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
DELYS THYROID CANCER UP
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
DAZARD UV RESPONSE CLUSTER G4
MCMURRAY TP53 HRAS COOPERATION RESPONSE UP
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
BIOCARTA FREE PATHWAY
BIOCARTA ETS PATHWAY
NCI NFAT TFPATHWAY
ZHOU INFLAMMATORY RESPONSE LIVE UP
ONDER CDH1 TARGETS 3 DN
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
DAZARD RESPONSE TO UV NHEK UP
NEWMAN ERCC6 TARGETS UP
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX CHUK KPNA3 NFKB2 NFKBIB REL IKBKG NFKB1 NFKBIE RELB NFKBIA RELA TNIP2
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
TAVOR CEBPA TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS DN
GAURNIER PSMD4 TARGETS
GRANDVAUX IFN RESPONSE NOT VIA IRF3
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
NETPATH TNF ALPHA PATHWAY UP
MARKEY RB1 CHRONIC LOF DN
NCI AMB2 NEUTROPHILS PATHWAY
NOJIMA SFRP2 TARGETS DN
NGUYEN NOTCH1 TARGETS DN
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
ZIRN TRETINOIN RESPONSE UP
LEE LIVER CANCER MYC E2F1 UP
SESTO RESPONSE TO UV C3
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
CORUM TNF-ALPHA/NF-KAPPA B SIGNALING COMPLEX RPL6 RPL30 RPS13 CHUK DDX3X NFKB2 NFKBIB REL IKBKG NFKB1 MAP3K8 RELB GLG1 NFKBIA RELA TNIP2 GTF2I
ZHOU INFLAMMATORY RESPONSE FIMA UP
SENESE HDAC2 TARGETS UP
ZHU CMV ALL UP
GRUETZMANN PANCREATIC CANCER UP
ROZANOV MMP14 TARGETS UP
ABE VEGFA TARGETS 2HR
OKUMURA INFLAMMATORY RESPONSE LPS
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
KEGG TYPE I DIABETES MELLITUS
KRIGE AMINO ACID DEPRIVATION
AMIT EGF RESPONSE 60 MCF10A
KOMMAGANI TP63 GAMMA TARGETS
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
RHEIN ALL GLUCOCORTICOID THERAPY UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
LEONARD HYPOXIA
CHEN LVAD SUPPORT OF FAILING HEART DN
BIOCARTA EPONFKB PATHWAY
RICKMAN TUMOR DIFFERENTIATED WELL VS MODERATELY DN
DORN ADENOVIRUS INFECTION 32HR DN
LEE LIVER CANCER MYC TGFA UP
HALMOS CEBPA TARGETS UP
WU CELL MIGRATION
WALLACE PROSTATE CANCER RACE UP
CHANDRAN METASTASIS DN
SAGIV CD24 TARGETS DN
ONDER CDH1 SIGNALING VIA CTNNB1
ZHONG RESPONSE TO AZACITIDINE AND TSA UP
ST INTERFERON GAMMA PATHWAY
MAHADEVAN RESPONSE TO MP470 DN
UROSEVIC RESPONSE TO IMIQUIMOD
HARRIS HYPOXIA
NETPATH KIT RECEPTOR PATHWAY UP
SOUCEK MYC TARGETS
BIOCARTA IL5 PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 6HR DN
IZADPANAH STEM CELL ADIPOSE VS BONE UP
ZHAN MULTIPLE MYELOMA LB DN
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
NETPATH IL 3 PATHWAY UP
DAUER STAT3 TARGETS UP
LIANG SILENCED BY METHYLATION 2
DER IFN ALPHA RESPONSE UP
MENSE HYPOXIA UP
LEE LIVER CANCER ACOX1 UP
WANG ESOPHAGUS CANCER PROGRESSION UP
BERENJENO TRANSFORMED BY RHOA FOREVER DN
DAZARD UV RESPONSE CLUSTER G2
EINAV INTERFERON SIGNATURE IN CANCER
MCLACHLAN DENTAL CARIES DN
KEGG ALLOGRAFT REJECTION
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
ZHU CMV 8 HR UP
BIERIE INFLAMMATORY RESPONSE TGFB1
SANA TNF SIGNALING UP
BIOCARTA INFLAM PATHWAY
SENESE HDAC1 AND HDAC2 TARGETS UP
NCI IL27PATHWAY
ONDER CDH1 TARGETS 2 DN
NAKAJIMA MAST CELL
AMIT EGF RESPONSE 240 HELA
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
VICENT METASTASIS DN
SENESE HDAC3 TARGETS UP
BUDHU LIVER CANCER METASTASIS UP
KEGG CHEMOKINE SIGNALING PATHWAY
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
KOBAYASHI EGFR SIGNALING 6HR DN
JISON SICKLE CELL DISEASE UP
NCI NFKAPPABCANONICALPATHWAYTNFAIP3
DASU IL6 SIGNALING UP
HUPER BREAST BASAL VS LUMINAL UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
FUNG IL2 TARGETS WITH STAT5 BINDING SITES T1
ZUCCHI METASTASIS DN
BRUECKNER TARGETS OF MIRLET7A3 UP
SMID BREAST CANCER BASAL UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
yersinia enterocolitica wap bcyersinia enterocolitica p60 bl6pseudomonas aeruginosa fdr440GeneSet Name
0.01876 0.05939 0.00516NETPATH_TGFBETA_RECEPTOR_PATHWAY_UP
0.00001 0.00000 0.00000NETPATH_IL_1_PATHWAY_UP
0.00013 0.00040 0.00131GERY_CEBP_TARGETS
0.00024 0.00146 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.00010 0.00994 0.00843NETPATH_IL_2_PATHWAY_UP
0.00001 0.00000 0.01471NCI_IL23PATHWAY
0.00014 0.00038 0.00005NETPATH_EGFR1_PATHWAY_UP
0.00156 0.00272 0.06732NCI_IL12_2PATHWAY
0.00000 0.00010 0.01426NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.01695 0.05415 0.01860NCI_REG_GR_PATHWAY
0.00001 0.00711 0.00726NETPATH_IL_5_PATHWAY_UP
0.00844 0.02204 0.03042ST_P38_MAPK_PATHWAY
0.00841 0.04794 0.07208NCI_IL1PATHWAY
0.00001 0.00016 0.04269NETPATH_IL_9_PATHWAY_UP
0.00052 0.00709 0.00003NETPATH_IL_7_PATHWAY_UP
0.00000 0.00000 0.03716NETPATH_IL_6_PATHWAY_UP
0.00059 0.00108 0.01645BIOCARTA_IL10_PATHWAY
0.00000 0.00021 0.01700GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.04118 0.03650 0.01042BIOCARTA_STEM_PATHWAY
0.01359 0.05121 0.00100BIOCARTA_NFKB_PATHWAY
0.00000 0.00010 0.00044MAHAJAN_RESPONSE_TO_IL1A_UP
0.00001 0.00006 0.01567WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.00120 0.15490 0.05018VARELA_ZMPSTE24_TARGETS_UP
0.00741 0.00054 0.02145REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS
0.00004 0.04591 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00011 0.00114 0.06380BIOCARTA_IL1R_PATHWAY
0.02335 0.00309 0.11846KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00001 0.00297 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.01065 0.00543 0.00347LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.06007 0.00563 0.00064IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.00018 0.00021 0.15015AMIT_EGF_RESPONSE_40_HELA
0.02677 0.00618 0.03539BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.04401 0.09354 0.13226KIM_WT1_TARGETS_12HR_DN
0.03703 0.11861 0.00520AMIT_EGF_RESPONSE_480_HELA
0.07031 0.01900 0.00005JEON_SMAD6_TARGETS_UP
0.00000 0.00184 0.00052THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00012 0.00708 0.11741TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.06378 0.12093 0.00799BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.00000 0.00000 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.01624 0.00341 0.00037DORN_ADENOVIRUS_INFECTION_48HR_DN
0.00372 0.17439 0.05096KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.00001 0.01647 0.01820MARKEY_RB1_ACUTE_LOF_UP
0.00000 0.00000 0.01060AMIT_SERUM_RESPONSE_60_MCF10A
0.00313 0.10560 0.04178GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.00178 0.05253 0.00625HAN_SATB1_TARGETS_DN
0.02588 0.00162 0.00157SABATES_COLORECTAL_ADENOMA_UP
0.15912 0.16021 0.11245REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY
0.10867 0.02287 0.16505MCBRYAN_PUBERTAL_BREAST_3_4WK_UP
0.00439 0.02147 0.00883RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.02102 0.04686 0.15097WOTTON_RUNX_TARGETS_UP
0.11363 0.12805 0.00848LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.00000 0.00012 0.00009REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00000 0.00069 0.05479SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.00000 0.00032 0.02769GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.00000 0.00029 0.00068AMIT_EGF_RESPONSE_120_HELA
0.07823 0.01398 0.03208NCI_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.02104 0.07528 0.01277BIOCARTA_RANKL_PATHWAY
0.00178 0.07195 0.01555FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.00000 0.00050 0.00001MCLACHLAN_DENTAL_CARIES_UP
0.00007 0.00305 0.09246SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.00000 0.00000 0.13382PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00205 0.00563 0.16834LEE_LIVER_CANCER_E2F1_UP
0.00040 0.00251 0.01964HELLER_SILENCED_BY_METHYLATION_UP
0.09819 0.12090 0.19127KERLEY_RESPONSE_TO_CISPLATIN_UP
0.00632 0.00593 0.04904BOWIE_RESPONSE_TO_TAMOXIFEN
0.00824 0.00018 0.00710SMID_BREAST_CANCER_LUMINAL_B_DN
0.00000 0.00000 0.00027ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.03066 0.06583 0.12159NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.06676 0.14981 0.06647VANTVEER_BREAST_CANCER_ESR1_DN
0.00323 0.00061 0.00130DORN_ADENOVIRUS_INFECTION_24HR_DN
0.03002 0.03292 0.00018FALVELLA_SMOKERS_WITH_LUNG_CANCER
0.00000 0.00000 0.00218VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00001 0.04624 0.04896BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.01652 0.11365 0.02164NCI_P53DOWNSTREAMPATHWAY
0.11680 0.16341 0.14498CORUM_IKBEPSILON-RELA-CREL_COMPLEX
0.00000 0.00016 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.18767 0.03748 0.07697ST_STAT3_PATHWAY
0.00177 0.01680 0.09337KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.09537 0.04570 0.06924HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN
0.00025 0.00029 0.09974HUANG_DASATINIB_RESISTANCE_UP
0.00081 0.00005 0.19807CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.00001 0.00034 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00007 0.00176 0.00001CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00107 0.00038 0.00000MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00114 0.00037 0.00495ZHANG_INTERFERON_RESPONSE
0.04376 0.02752 0.02296KEGG_ASTHMA
0.02108 0.01204 0.00240SESTO_RESPONSE_TO_UV_C1
0.00829 0.00954 0.00017CROONQUIST_STROMAL_STIMULATION_UP
0.08684 0.00258 0.19008BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.00821 0.13433 0.01311SIMBULAN_UV_RESPONSE_NORMAL_UP
0.00014 0.03216 0.02984KIM_LRRC3B_TARGETS
0.00023 0.01137 0.00881HORIUCHI_WTAP_TARGETS_UP
0.00001 0.00424 0.14135WOO_LIVER_CANCER_RECURRENCE_UP
0.01175 0.00175 0.04477DORN_ADENOVIRUS_INFECTION_12HR_UP
0.00124 0.00504 0.08542CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00132 0.12825 0.19187DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.00277 0.00111 0.15521KEGG_JAK_STAT_SIGNALING_PATHWAY
0.02600 0.06070 0.06795FUNG_IL2_SIGNALING_2
0.17539 0.01467 0.00130TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN
0.00563 0.04762 0.00222DER_IFN_BETA_RESPONSE_UP
0.00012 0.02538 0.00448DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.00001 0.00164 0.00027DIRMEIER_LMP1_RESPONSE_LATE_UP
0.00572 0.00934 0.00573SEIKE_LUNG_CANCER_POOR_SURVIVAL
0.00004 0.00009 0.00347BIOCARTA_CYTOKINE_PATHWAY
0.00004 0.00040 0.13279TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.09968 0.08747 0.04261MUELLER_METHYLATED_IN_GLIOBLASTOMA
0.00000 0.00018 0.00000BASSO_CD40_SIGNALING_UP
0.00000 0.00000 0.00002NAGASHIMA_NRG1_SIGNALING_UP
0.00006 0.00021 0.01502MARZEC_IL2_SIGNALING_UP
0.00120 0.10880 0.02173ENK_UV_RESPONSE_EPIDERMIS_DN
0.16203 0.05840 0.03840ZERBINI_RESPONSE_TO_SULINDAC_UP
0.01616 0.03028 0.00878WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.01752 0.00030 0.01404CROMER_TUMORIGENESIS_UP
0.01642 0.17993 0.00103FRIDMAN_SENESCENCE_UP
0.08739 0.16824 0.19091WU_HBX_TARGETS_2_DN
0.00006 0.00018 0.00002MAHADEVAN_RESPONSE_TO_MP470_UP
0.02287 0.03661 0.02454CORRE_MULTIPLE_MYELOMA_UP
0.00007 0.01472 0.00002FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.03958 0.06399 0.03234KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.08849 0.07744 0.09425NCI_SYNDECAN_PATHWAY
0.00025 0.01462 0.04172SANA_RESPONSE_TO_IFNG_UP
0.18469 0.18839 0.06821SIG_CD40PATHWAYMAP
0.00695 0.07814 0.00027KEGG_LEISHMANIA_INFECTION
0.00334 0.00917 0.02293WU_HBX_TARGETS_1_UP
0.00001 0.00807 0.00550CHEN_HOXA5_TARGETS_9HR_UP
0.00893 0.10907 0.10298WANG_RECURRENT_LIVER_CANCER_DN
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.00008 0.00398 0.00002GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00014 0.00489 0.03175CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.00258 0.12076 0.15080MURAKAMI_UV_RESPONSE_6HR_UP
0.00019 0.02031 0.06733BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.00001 0.00236 0.00512MOSERLE_IFNA_RESPONSE
0.00000 0.00004 0.09494FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.00001 0.00162 0.06554WANG_METHYLATED_IN_BREAST_CANCER
0.02830 0.12689 0.00861BIOCARTA_ASBCELL_PATHWAY
0.00001 0.01901 0.00013SENESE_HDAC1_TARGETS_UP
0.03136 0.04786 0.08512LIU_TARGETS_OF_VMYB_VS_CMYB_DN
0.00000 0.00039 0.00002KIM_WT1_TARGETS_UP
0.00277 0.00405 0.00709ONDER_CDH1_TARGETS_1_DN
0.01094 0.00200 0.01678KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.00514 0.01449 0.02115BIOCARTA_GRANULOCYTES_PATHWAY
0.05123 0.04457 0.03244LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.01076 0.01447 0.02759DORSAM_HOXA9_TARGETS_DN
0.00045 0.00028 0.15685ELVIDGE_HYPOXIA_BY_DMOG_UP
0.00001 0.00086 0.00020AMIT_EGF_RESPONSE_120_MCF10A
0.00000 0.00000 0.00011OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.07837 0.18489 0.00131BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.13932 0.07228 0.01010SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN
0.00024 0.02844 0.00044PRAMOONJAGO_SOX4_TARGETS_UP
0.00000 0.00000 0.06556PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.05475 0.19301 0.00518BIOCARTA_PML_PATHWAY
0.05073 0.00794 0.17577REACTOME_CLASS_A1_RHODOPSIN_LIKE_RECEPTORS
0.00000 0.00011 0.00068ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.07725 0.04211 0.05310TENEDINI_MEGAKARYOCYTE_MARKERS
0.04260 0.06739 0.11152MCBRYAN_PUBERTAL_BREAST_4_5WK_UP
0.00093 0.02533 0.00311NETPATH_IL_1_PATHWAY
0.00000 0.00029 0.00003LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.04458 0.14753 0.10393XU_RESPONSE_TO_TRETINOIN_UP
0.06631 0.17985 0.01001HOFMANN_CELL_LYMPHOMA_DN
0.00006 0.00031 0.16459ELVIDGE_HYPOXIA_UP
0.06013 0.07364 0.14426CORUM_IKBBETA-RELA-CREL_COMPLEX
0.09294 0.11366 0.05731NCI_SYNDECAN_1_PATHWAY
0.00470 0.13260 0.01701BIOCARTA_NKT_PATHWAY
0.00000 0.00006 0.00002BROWNE_INTERFERON_RESPONSIVE_GENES
0.03831 0.09575 0.10447ROETH_TERT_TARGETS_UP
0.02964 0.01867 0.06129TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.00992 0.00330 0.01830BIOCARTA_LAIR_PATHWAY
0.00000 0.00058 0.00034KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.01700 0.14573 0.14732CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP
0.00218 0.00294 0.08419VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP
0.08630 0.08169 0.11392OSADA_ASCL1_TARGETS_DN
0.08498 0.08081 0.01705BIOCARTA_LYM_PATHWAY
0.00008 0.00356 0.00021NUYTTEN_EZH2_TARGETS_UP
0.00003 0.00201 0.00513DUTTA_APOPTOSIS_VIA_NFKB
0.01537 0.05105 0.00736DELYS_THYROID_CANCER_UP
0.00000 0.00018 0.00002DIRMEIER_LMP1_RESPONSE_EARLY
0.00850 0.14426 0.00011DER_IFN_GAMMA_RESPONSE_UP
0.00333 0.00427 0.01547DAZARD_UV_RESPONSE_CLUSTER_G4
0.00340 0.00872 0.10700MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP
0.00073 0.00079 0.06522BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.04388 0.18018 0.04271BIOCARTA_FREE_PATHWAY
0.00895 0.01583 0.11257BIOCARTA_ETS_PATHWAY
0.00259 0.15482 0.04224NCI_NFAT_TFPATHWAY
0.00000 0.00000 0.00010ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.01083 0.00026 0.00194ONDER_CDH1_TARGETS_3_DN
0.00401 0.02280 0.00016HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.10223 0.02528 0.05763NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.00012 0.10917 0.01078NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00004 0.01519 0.00135WINTER_HYPOXIA_METAGENE
0.00323 0.01128 0.10778DAZARD_RESPONSE_TO_UV_NHEK_UP
0.01325 0.03258 0.03524NEWMAN_ERCC6_TARGETS_UP
0.05725 0.07034 0.00016CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_CHUK_KPNA3_NFKB2_NFKBIB_REL_IKBKG__NFKB1_NFKBIE_RELB__NFKBIA_RELA_TNIP2
0.00000 0.00056 0.12253GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.01106 0.06979 0.08516TAVOR_CEBPA_TARGETS_UP
0.00000 0.00000 0.00037FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.00000 0.00002GAURNIER_PSMD4_TARGETS
0.00368 0.00375 0.04085GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.03490 0.00980 0.01084SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.01532 0.17984 0.00318NETPATH_TNF_ALPHA_PATHWAY_UP
0.00565 0.00471 0.05680MARKEY_RB1_CHRONIC_LOF_DN
0.04505 0.17478 0.00315NCI_AMB2_NEUTROPHILS_PATHWAY
0.00893 0.01777 0.16491NOJIMA_SFRP2_TARGETS_DN
0.04992 0.05226 0.11301NGUYEN_NOTCH1_TARGETS_DN
0.00000 0.00007 0.02960AMIT_SERUM_RESPONSE_120_MCF10A
0.02213 0.00222 0.00002BROWNE_HCMV_INFECTION_2HR_UP
0.01696 0.13455 0.15080ZIRN_TRETINOIN_RESPONSE_UP
0.07080 0.00848 0.11981LEE_LIVER_CANCER_MYC_E2F1_UP
0.00406 0.00078 0.02538SESTO_RESPONSE_TO_UV_C3
0.00000 0.00109 0.00007GEISS_RESPONSE_TO_DSRNA_UP
0.00011 0.00272 0.03950GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.02956 0.00070 0.00499SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.17372 0.09809 0.00282CORUM_TNF-ALPHA/NF-KAPPA_B_SIGNALING_COMPLEX_RPL6_RPL30_RPS13_CHUK_DDX3X_NFKB2_NFKBIB_REL_IKBKG_NFKB1_MAP3K8_RELB_GLG1_NFKBIA_RELA_TNIP2__GTF2I
0.00001 0.00000 0.00013ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP
0.00006 0.13212 0.00858SENESE_HDAC2_TARGETS_UP
0.00018 0.03630 0.02420ZHU_CMV_ALL_UP
0.00480 0.11422 0.08530GRUETZMANN_PANCREATIC_CANCER_UP
0.03703 0.05243 0.13315ROZANOV_MMP14_TARGETS_UP
0.03825 0.13436 0.03241ABE_VEGFA_TARGETS_2HR
0.01782 0.00621 0.01148OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.00193 0.00058 0.00243LEE_LIVER_CANCER_HEPATOBLAST
0.00000 0.00000 0.00002NAGASHIMA_EGF_SIGNALING_UP
0.00156 0.06744 0.04277AMIT_DELAYED_EARLY_GENES
0.01030 0.01506 0.11089KEGG_TYPE_I_DIABETES_MELLITUS
0.00024 0.01090 0.08532KRIGE_AMINO_ACID_DEPRIVATION
0.00000 0.00000 0.00027AMIT_EGF_RESPONSE_60_MCF10A
0.07084 0.11613 0.06559KOMMAGANI_TP63_GAMMA_TARGETS
0.00001 0.00000 0.00195KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.04368 0.19873 0.11161RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.00000 0.00000 0.00010OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.00133 0.02220 0.01991SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00652 0.01346 0.00131LEONARD_HYPOXIA
0.05654 0.16613 0.15184CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN
0.17658 0.15613 0.00002BIOCARTA_EPONFKB_PATHWAY
0.02849 0.03894 0.00037RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN
0.01879 0.00369 0.00021DORN_ADENOVIRUS_INFECTION_32HR_DN
0.18770 0.02194 0.06140LEE_LIVER_CANCER_MYC_TGFA_UP
0.00154 0.00022 0.00031HALMOS_CEBPA_TARGETS_UP
0.09748 0.00037 0.11574WU_CELL_MIGRATION
0.00000 0.00029 0.15257WALLACE_PROSTATE_CANCER_RACE_UP
0.04629 0.12846 0.06578CHANDRAN_METASTASIS_DN
0.02459 0.18844 0.00091SAGIV_CD24_TARGETS_DN
0.01741 0.03049 0.00349ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.03095 0.07122 0.00816ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP
0.10742 0.17665 0.03236ST_INTERFERON_GAMMA_PATHWAY
0.00006 0.00072 0.02760MAHADEVAN_RESPONSE_TO_MP470_DN
0.00537 0.00167 0.00512UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.00004 0.00029 0.00003HARRIS_HYPOXIA
0.00004 0.00015 0.18259NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00001 0.00018 0.02994SOUCEK_MYC_TARGETS
0.08091 0.01559 0.14847BIOCARTA_IL5_PATHWAY
0.00000 0.00000 0.06809TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN
0.12181 0.06984 0.00336IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.00337 0.02608 0.08690ZHAN_MULTIPLE_MYELOMA_LB_DN
0.00219 0.00394 0.15531SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00000 0.00000 0.00028BILD_HRAS_ONCOGENIC_SIGNATURE
0.00000 0.00000 0.15088NETPATH_IL_3_PATHWAY_UP
0.06147 0.06189 0.00085DAUER_STAT3_TARGETS_UP
0.00007 0.00000 0.00005LIANG_SILENCED_BY_METHYLATION_2
0.01898 0.14030 0.00312DER_IFN_ALPHA_RESPONSE_UP
0.00167 0.17416 0.05632MENSE_HYPOXIA_UP
0.01516 0.02321 0.13286LEE_LIVER_CANCER_ACOX1_UP
0.00342 0.02833 0.01027WANG_ESOPHAGUS_CANCER_PROGRESSION_UP
0.00000 0.00332 0.11486BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.00772 0.01250 0.00228DAZARD_UV_RESPONSE_CLUSTER_G2
0.01324 0.06958 0.03104EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.00001 0.00065 0.00017MCLACHLAN_DENTAL_CARIES_DN
0.00070 0.00288 0.05771KEGG_ALLOGRAFT_REJECTION
0.00000 0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00004 0.00061 0.06119ZHU_CMV_8_HR_UP
0.00509 0.05248 0.00969BIERIE_INFLAMMATORY_RESPONSE_TGFB1
0.00000 0.00022 0.00000SANA_TNF_SIGNALING_UP
0.00006 0.00000 0.00030BIOCARTA_INFLAM_PATHWAY
0.00001 0.01129 0.00002SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00720 0.02901 0.10440NCI_IL27PATHWAY
0.00111 0.00022 0.00005ONDER_CDH1_TARGETS_2_DN
0.13350 0.02843 0.03210NAKAJIMA_MAST_CELL
0.00000 0.00964 0.01646AMIT_EGF_RESPONSE_240_HELA
0.00000 0.00030 0.00011HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.05211 0.00019 0.06875SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.08565 0.15093 0.12829VICENT_METASTASIS_DN
0.00001 0.00979 0.01005SENESE_HDAC3_TARGETS_UP
0.04554 0.19600 0.06612BUDHU_LIVER_CANCER_METASTASIS_UP
0.00276 0.06209 0.03885KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.00145 0.00423 0.11601CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.00000 0.00000 0.02749UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.14658 0.04783 0.00005KOBAYASHI_EGFR_SIGNALING_6HR_DN
0.00072 0.06359 0.19067JISON_SICKLE_CELL_DISEASE_UP
0.00132 0.04764 0.01645NCI_NFKAPPABCANONICALPATHWAY
0.00001 0.00177 0.00711DASU_IL6_SIGNALING_UP
0.02163 0.00812 0.11240HUPER_BREAST_BASAL_VS_LUMINAL_UP
0.00000 0.00037 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.11670 0.14788 0.10037FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1
0.00010 0.04370 0.00002ZUCCHI_METASTASIS_DN
0.00513 0.04236 0.12920BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.00269 0.00022 0.03515SMID_BREAST_CANCER_BASAL_UP